Correlation of P38 Mitogen-Activated Protein Kinase Expression to Clinical Stage in Nasopharyngeal Carcinoma by Farhat, Farhat et al.
 _______________________________________________________________________________________________________________________________ 
1982                                                                                                                                                                                              https://www.id-press.eu/mjms/index 
 
ID Design Press, Skopje, Republic of Macedonia 
Open Access Macedonian Journal of Medical Sciences. 2018 Nov 25; 6(11):1982-1985. 
https://doi.org/10.3889/oamjms.2018.355 
eISSN: 1857-9655 
Basic Science 
 
 
  
 
Correlation of P38 Mitogen-Activated Protein Kinase Expression 
to Clinical Stage in Nasopharyngeal Carcinoma 
 
 
Farhat Farhat
1*
, Elvita Rahmi Daulay
2
, Jessy Chrestella
3
, Rizalina Arwinati Asnir
1
, Ashri Yudhistira
1
, Riko Radityatama 
Susilo
1
 
 
1
Universitas Sumatera Utara Fakultas Kedokteran, Otorhynolaryngology Head and Neck Surgery Jl. Dr. T. Mansyur No. 9, 
Medan, North Sumatera 20155, Indonesia; 
2
Universitas Sumatera Utara Fakultas Kedokteran, Radiology Medan, North 
Sumatera, Indonesia; 
3
Universitas Sumatera Utara Fakultas Kedokteran, Pathology Medan, Sumatera Utara, Indonesia 
 
Citation: Farhat F, Daulay ER, Chrestella J, Asnir RA, 
Yudhistira A, Susilo RR. Correlation of P38 Mitogen-
Activated Protein Kinase Expression to Clinical Stage in 
Nasopharyngeal Carcinoma. Open Access Maced J Med 
Sci. 2018 Nov 25; 6(11):1982-1985. 
https://doi.org/10.3889/oamjms.2018.355 
Keywords: p38 MAPK; Nasopharyngeal carcinoma; 
Clinical stage; Correlation; Biomarker 
*Correspondence: Farhat Farhat. Universitas Sumatera 
Utara Fakultas Kedokteran, Otorhinolaryngology Head 
and Neck Surgery Jl. Dr T. Mansyur No.9, Medan, North 
Sumatera 20155, Indonesia. E-mail: farhat@usu.ac.id 
Received: 04-Sep-2018; Revised: 02-Nov-2018; 
Accepted: 04-Nov-2018; Online first: 19-Nov-2018 
Copyright: © 2018 Farhat Farhat, Elvita Rahmi Daulay, 
Jessy Chrestella, Rizalina Arwinati Asnir, Ashri Yudhistira, 
Riko Radityatama Susilo. This is an open-access article 
distributed under the terms of the Creative Commons 
Attribution-NonCommercial 4.0 International License (CC 
BY-NC 4.0) 
Funding: This research did not receive any financial 
support 
Competing Interests: The authors have declared that no 
competing interests exist 
 
 
 
 
 
 
 
Abstract 
BACKGROUND: Nasopharyngeal carcinoma (NPC) is uncommon and usually diagnosed at the advanced stage. 
A subfamily of mitogen-activated protein kinase which is called p38 mitogen-activated protein kinase (MAPK) 
involved in response to stress, and plays an important role in cell regulation. There is a suggestion that p38 
mitogen-activated protein kinase could be a potential biomarker to determine the clinical stage of nasopharyngeal 
carcinoma.  
AIM: The aim of this study is for observing and analysing the correlation of p38 mitogen-activated protein kinase 
expression in regards to nasopharyngeal carcinoma patient’s clinical stage.  
METHODS: This study involved 126 nasopharyngeal carcinoma patients admitted to Haji Adam Malik General 
Hospital.  
RESULTS: The result of this study indicates that nasopharyngeal carcinoma mostly found in the age group 41-60 
years, male, non-keratinizing squamous cell carcinoma, and stage IV group. In immunohistochemistry evaluation, 
most of p38 mitogen-activated protein kinase overexpressed in non-keratinizing squamous cell carcinoma, T3-T4, 
N2-N3 and clinical stage III-IV. Spearman’s test for categorical correlation yield p-value of < 0.001.  
CONCLUSION: In conclusion, there is a significant correlation between p38 mitogen-activated protein kinase 
expression and the clinical stage of nasopharyngeal carcinoma. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Introduction 
 
Nasopharyngeal carcinoma (NPC) is not a 
rare entity, which has a distinct distribution especially 
in Asia [ 1 ]  [ 2 ]  [ 3 ]  [ 4 ]  [ 5 ] . There are more than 
13.000 new cases of NPC in Indonesia and 
associated with a high mortality rate [1] [6]. The 
aetiology of NPC is considered to be related to 
environmental and genetic factors as well as EBV 
infection [7] [8]. Because of the location of NPC is in 
the silent and painless area; therefore the disease is 
usually diagnosed at the advanced stages; hence 
early detection of NPC is difficult [ 9 . Regulation of 
signaling molecules in intracellular signal 
transduction, which regulate cell proliferation, 
apoptosis, and adhesion, underlines the basis of 
NPC pathogenesis [10] [11] [12] [13] [14] [15] [16] 
[17]. 
Mitogen-activated protein kinase (MAPK) is an 
important signal molecule that affects a variety of 
cellular process such as proliferation, differentiation, 
migration, and apoptosis [18] [22]. Aside from its 
physiological functions, MAPK also plays a key role 
in many pathological conditions including cancer, 
cardiac hypertrophy, and diabetes [23] [24] [25] [26]. 
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Two distinct classes of MAPKs have been 
identified so far: p42-p44 (ERK) MAPKs inducible by; 
and SAPKs (Stress-Activated Protein Kinases), which 
include p38 MAPKs, and p46-p54 JNKs inducible by 
cellular stress [24] [25]. Each MAPK class responds 
to distinct stimuli and induces a specific biological 
response, and they proofed to have a crucial role 
in cancer development [26]. 
The p38 MAPKs are a conserved subfamily of 
MAPKs involved in response to stress found in 
eukaryotic cells from yeast to mammals. p38 was 
found in 1994 as a MAP kinase targeted by endotoxin 
and hyperosmolarity in mammalian cells [27]. In the 
development of NPC, p38 MAPK activation plays an 
important role both in the ability to protect EBV-
infected Raji cells from apoptosis and also for 
promoting EBV lytic gene expression [17]. 
The p38 MAPKs have been proposed as a 
novel biomarker for predicting the clinical stage of 
NPC [19] [20]. Considering the importance of a 
biomarker for NPC, the primary goal of the current 
study was to explore the prevalence and expression 
of p38 MAPK and their possible correlation to the 
clinical stage of NPC. This study might provide 
supportive evidence for the role of p38 MAPK in the 
clinical stage of NPC. 
This study was analytic research, and we used 
paraffin samples of 126 NPC patients to analyse the 
correlation of p38 MAPK overexpression to the clinical 
stage of NPC. 
 
 
Material and Methods 
 
During July to October 2017, research with 
126 samples of NPC patients was established in 
Adam Malik General Hospital, Medan. The samples 
were taken in 2015-2016 based on history taking, 
physical examination, and nasopharyngeal 
histopathological biopsy. The criteria include patients 
with NPC histopathologically examined and not yet 
received any radiotherapy, chemotherapy, or 
combination of both. To obtain an adequate result, 
non-probability consecutive sampling was used to 
receive a minimum of 68 patients in this study. 
Paraffin-embedded pathological specimens of 
nasopharyngeal histopathological biopsy were 
obtained. All of these resection samples were treated 
with a standard fixation, dissection, and processing 
protocol. The blocks were then cut into 4 mm 
sections and processed for immunohistochemistry. 
After being washed with phosphate-buffered saline, 
the specimens were incubated with the primary 
antibody using GENETEX human p38 MAPK 
antibody. 
 
Figure 1: Cytoplasmic expression of p38 MAPK in non-
keratinizing squamous cell nasopharyngeal carcinoma (x 400) 
 
The tissues were examined using 
immunohistochemistry technique under fluorescent 
microscope evaluating the immunoreaction of p38 
MAPK. Three pathologists who were blinded to the 
patients’ clinicopathological data independently 
evaluated the p38 MAPK expressions. The results 
were evaluated using immunoreactivity score (score 
obtained by multiplying width score with intensity 
score) [21]. 
This study was approved by t h e  Health 
Research Ethical Committee of t h e  Medical 
Faculty of Universitas Sumatera Utara. 
To define the correlation in this study, 
SPSS ver. 22 software was used to conduct all the 
statistical analysis. The association was identified by 
using Spearman’s correlation, in which p < 0.05 was 
considered as statistically significant. 
 
 
Results 
 
There were 126 patients with NPC involved 
in this study that has fulfilled the study requirement. 
The presentation of demographic data was shown in 
table 1. Distributions of age-specific rates of NPC 
shows that NPC incidence increases simultaneously 
with age, but fells of after 60 years. Despite the 
same ratio of male: female over the year, the 
number of NPC based on gender are higher in men 
compared to women. After immunohistochemistry 
examination, the most frequent histological type was 
non-keratinizing squamous cell carcinoma. For the 
clinical stage, most of the samples in the study was 
stage IV. The main focus of this study showed 
most of p38 MAPK over-expressed was in non-
keratinizing squamous cell carcinoma (63.5%), T3-T4 
primary tumour size (53.1%), cervical nodes 
enlargement in the N2-N3 group (65.1%) and clinical 
stage in the III-IV group (71.8%). 
The association uses Spearman's test to 
categorise the correlation which results in the p-value 
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of < 0.001 indicating that the correlation of clinical 
staging and the expression of p38 MAPK is 
statistically significant. 
Table 1: Demographic Data and Correlation of p38 MAPK and 
Clinical Stage in NPC Patients 
Characteristic  p38 MAPK  Expression   P 
Overexpression % Negative %  
Age (y) 
≤ 20   3  2.4  4 3.2  
21-40 21  16.7  7 5.6  
41-60 59  46.8 13 10.3  
> 60 17  13.5  2 1.6  
Sex 
Male 69  54.8 21 16,7  
Female 31  24.6  5 4.0  
Histopathology 
Keratinizing SCC   8  6.3  0 0.0  
Non-keratinizing SCC 80  63.5 20 15.9  
Undifferentiated carcinoma 12  9.5  6 4.8  
Primary Tumor (T) 
T1 
T2 
12 
21 
 9.5 
16.7 
13 
11 
10.3 
8.7 
 
T3 T4 40 
27 
 31.7 
21.4 
 1 
1 
0.8 
0.8 
 
Nodes (N) 
N0 
N1 
  8 
11 
 7.8 
10.7 
    13 
4 
 12.6 
3.9 
 
N2 N3 18 
49 
 17.5 
47.6 
0 
0 
 0.0 
0.0 
 
Clinical Staging 
I 
II 
  4 
  8 
 3.9 
7.8 
     9 
     5 
 8.7 
4.9 
<
0.001 
III 16 15.5 2     1.9 
IV 58 56.3 1     1.0 
*p < 0.05 = statistically significant. 
 
 
Discussion 
 
In this study, the largest age group of a 
patient diagnosed with NPC is between 41-60 years 
old (57.1%). Similar to Adham et al., (2012), 40-49 
years old is the highest age of the NPC patients found 
in their study [1]. This occurred because the DNA 
repair mechanism function and immune system have 
been lessened as mutation develops at the age of 
more than 40 years [5] [6] [13]. 
In our study, a trend was conducted, with 
71.4% male and 28.6% female resulting in a 2.5:1 
ratio. The male: female ratio was relatively stable 
over the years. In Cao (2011) study, the 
predominance was found as well with the incidence 
rate of NPC was less in women than in men, with a 
ratio of 2-3:1 [3]. The exposure to environmental 
pollution from occupation and lifestyle caused males 
got a higher ratio than females diagnosed with NPC 
[2] [5]. 
In our study, non-keratinizing squamous cell 
carcinoma (79.4%) was the most common form of 
NPC, similar to the studies done in other high-risk 
countries. In an endemic area, over 90% of NPC is 
non-keratinizing squamous cell carcinoma [2] [4] [5]. 
The p38 pathway has also been playing a 
role in the activation of p53 and p53-mediated 
apoptosis [18] [28] [29]. Many cancers are associated 
with decreased p38 activity because in the majority of 
cancers studied, reduced p38 activity implicated in the 
continuous cell proliferation, with downstream target 
activation such as ATF-2 and Elk-1 [30] [33]. 
Many factors support the role of p38 MAPK as 
a tumour suppressor, and the negative regulation of 
cell cycle and apoptotic induction mediate this p38α 
function, although terminal differentiation induction 
also supports tumour suppressor [24] [34] [35]. 
However, p38 MAPK as well as an oncogenic 
function that is mediated by the involvement of 
cancer progression processes, such as invasion, 
inflammation, and angiogenesis [36] [40]. The 
conclusion of this study is a statistically significant 
correlation between clinical staging and the expression 
of p38 MAPK. Further research with larger and 
multiple centres is required for assessing the role of 
p38 MAPK in the progression of nasopharyngeal 
cancer. 
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